![](/img/cover-not-exists.png)
Optimal methotrexate dose is associated with better clinical outcomes than non-optimal dose in daily practice: results from the ESPOIR early arthritis cohort
Gaujoux-Viala, Cécile, Rincheval, Nathalie, Dougados, Maxime, Combe, Bernard, Fautrel, BrunoLanguage:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2017-211268
Date:
September, 2017
File:
PDF, 711 KB
english, 2017